Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Ambulance use for 'primary care' problems: an ethnographic study of seeking and providing help in a UK ambulance service.

Booker MJ, Purdy S, Barnes R, Shaw ARG.

BMJ Open. 2019 Oct 10;9(10):e033037. doi: 10.1136/bmjopen-2019-033037.

2.

Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy.

Jang SM, Pai MP, Shaw AR, Mueller BA.

Crit Care Med. 2019 Nov;47(11):e863-e871. doi: 10.1097/CCM.0000000000003955.

PMID:
31397714
3.

TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study.

Ridd MJ, Edwards L, Santer M, Chalmers JR, Waddell L, Marriage D, Muller I, Roberts K, Garfield K, Coast J, Selman L, Clement C, Shaw ARG, Angier E, Blair PS, Turner NL, Taylor J, Kai J, Boyle RJ.

BMJ Open. 2019 May 9;9(5):e028428. doi: 10.1136/bmjopen-2018-028428.

4.

'Primary care sensitive' situations that result in an ambulance attendance: a conversation analytic study of UK emergency '999' call recordings.

Booker MJ, Shaw ARG, Purdy S, Barnes R.

BMJ Open. 2018 Nov 25;8(11):e023727. doi: 10.1136/bmjopen-2018-023727.

5.

Reducing attrition within clinical trials: The communication of retention and withdrawal within patient information leaflets.

Kearney A, Rosala-Hallas A, Bacon N, Daykin A, Shaw ARG, Lane AJ, Blazeby JM, Clarke M, Williamson PR, Gamble C.

PLoS One. 2018 Oct 31;13(10):e0204886. doi: 10.1371/journal.pone.0204886. eCollection 2018.

6.

Understanding usual care for patients with multimorbidity: baseline data from a cluster-randomised trial of the 3D intervention in primary care.

Chaplin K, Bower P, Man MS, Brookes ST, Gaunt D, Guthrie B, Mann C, Mercer SW, Rafi I, Shaw ARG, Salisbury C.

BMJ Open. 2018 Aug 29;8(8):e019845. doi: 10.1136/bmjopen-2017-019845.

7.

Gaseous Emissions from Wastewater Facilities.

Koh SH, Shaw AR.

Water Environ Res. 2018 Oct 1;90(10):1563-1575. doi: 10.2175/106143018X15289915807308. Review.

PMID:
30126492
8.

Preparation times and costs for various solutions used for continuous renal replacement therapy.

Shaw AR, Chaijamorn W, Clark JS, Mueller BA.

Am J Health Syst Pharm. 2018 Jun 1;75(11):808-815. doi: 10.2146/ajhp160741.

PMID:
29802114
9.

Gaseous Emissions from Wastewater Facilities.

Koh SH, Shaw AR.

Water Environ Res. 2017 Oct 1;89(10):1268-1280. doi: 10.2175/106143017X15023776270296. Review.

PMID:
28954659
10.

Identifying research priorities for effective retention strategies in clinical trials.

Kearney A, Daykin A, Shaw ARG, Lane AJ, Blazeby JM, Clarke M, Williamson P, Gamble C.

Trials. 2017 Aug 31;18(1):406. doi: 10.1186/s13063-017-2132-z.

11.

Antibiotic Dosing in Continuous Renal Replacement Therapy.

Shaw AR, Mueller BA.

Adv Chronic Kidney Dis. 2017 Jul;24(4):219-227. doi: 10.1053/j.ackd.2017.05.004. Review.

PMID:
28778361
12.

Seeking ambulance treatment for 'primary care' problems: a qualitative systematic review of patient, carer and professional perspectives.

Booker MJ, Purdy S, Shaw ARG.

BMJ Open. 2017 Aug 3;7(8):e016832. doi: 10.1136/bmjopen-2017-016832. Review.

13.

A systematic review to identify and assess the effectiveness of alternatives for people over the age of 65 who are at risk of potentially avoidable hospital admission.

Huntley AL, Chalder M, Shaw ARG, Hollingworth W, Metcalfe C, Benger JR, Purdy S.

BMJ Open. 2017 Aug 1;7(7):e016236. doi: 10.1136/bmjopen-2017-016236. Review.

14.

Ex vivo Ceftolozane/Tazobactam Clearance during Continuous Renal Replacement Therapy.

Chaijamorn W, Shaw AR, Lewis SJ, Mueller BA.

Blood Purif. 2017;44(1):16-23. doi: 10.1159/000455897. Epub 2017 Feb 25.

PMID:
28237981
15.

Modelling the link amongst fine-pore diffuser fouling, oxygen transfer efficiency, and aeration energy intensity.

Garrido-Baserba M, Sobhani R, Asvapathanagul P, McCarthy GW, Olson BH, Odize V, Al-Omari A, Murthy S, Nifong A, Godwin J, Bott CB, Stenstrom MK, Shaw AR, Rosso D.

Water Res. 2017 Mar 15;111:127-139. doi: 10.1016/j.watres.2016.12.027. Epub 2016 Dec 19.

PMID:
28064087
16.

Gaseous Emissions from Wastewater Facilities.

Koh SH, Shaw AR.

Water Environ Res. 2016 Oct;88(10):1249-60. doi: 10.2175/106143016X14696400494812. Review.

PMID:
27620089
17.

Fabrication and in vitro characterization of gadolinium-based nanoclusters for simultaneous drug delivery and radiation enhancement.

Yoo SS, Guo L, Sun X, Shaw AR, Yuan Z, Löbenberg R, Roa WH.

Nanotechnology. 2016 Sep 23;27(38):385104. doi: 10.1088/0957-4484/27/38/385104. Epub 2016 Aug 17.

PMID:
27533280
18.

We Underdose Antibiotics in Patients on CRRT.

Shaw AR, Chaijamorn W, Mueller BA.

Semin Dial. 2016 Jul;29(4):278-80. doi: 10.1111/sdi.12496. Epub 2016 Apr 15. Review.

19.

BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair.

Ismail IH, Dronyk A, Hu X, Hendzel MJ, Shaw AR.

Cell Cycle. 2016;15(1):84-94. doi: 10.1080/15384101.2015.1121322.

20.

Linking biofilm growth to fouling and aeration performance of fine-pore diffuser in activated sludge.

Garrido-Baserba M, Asvapathanagul P, McCarthy GW, Gocke TE, Olson BH, Park HD, Al-Omari A, Murthy S, Bott CB, Wett B, Smeraldi JD, Shaw AR, Rosso D.

Water Res. 2016 Mar 1;90:317-328. doi: 10.1016/j.watres.2015.12.011. Epub 2015 Dec 18.

PMID:
26760484
21.

Gaseous Emissions from Wastewater Facilities.

Koh SH, Shaw AR.

Water Environ Res. 2015 Oct;87(10):1167-77. doi: 10.2175/106143015X14338845155543.

PMID:
26420084
22.

Why do patients with 'primary care sensitive' problems access ambulance services? A systematic mapping review of the literature.

Booker MJ, Shaw AR, Purdy S.

BMJ Open. 2015 May 19;5(5):e007726. doi: 10.1136/bmjopen-2015-007726. Review.

23.

Layered gadolinium-based nanoparticle as a novel delivery platform for microRNA therapeutics.

Yoo SS, Razzak R, Bédard E, Guo L, Shaw AR, Moore RB, Roa WH.

Nanotechnology. 2014 Oct 24;25(42):425102. doi: 10.1088/0957-4484/25/42/425102. Epub 2014 Oct 3.

PMID:
25277286
24.

Managing clients' expectations at the outset of online Cognitive Behavioural Therapy (CBT) for depression.

Ekberg S, Barnes RK, Kessler DS, Malpass A, Shaw AR.

Health Expect. 2016 Jun;19(3):557-69. doi: 10.1111/hex.12227. Epub 2014 Aug 2.

25.

Relationship between Expectation Management and Client Retention in Online Cognitive Behavioural Therapy.

Ekberg S, Barnes RK, Kessler DS, Mirza S, Montgomery AA, Malpass A, Shaw AR.

Behav Cogn Psychother. 2015 Nov;43(6):732-43. doi: 10.1017/S1352465814000241. Epub 2014 Jun 24.

PMID:
24960277
26.

Human papillomavirus vaccines six years after approval.

Shaw AR.

Annu Rev Med. 2013;64:91-100. doi: 10.1146/annurev-med-061511-125226. Epub 2012 Nov 19. Review.

PMID:
23190152
27.

The rotavirus saga revisited.

Shaw AR.

Annu Rev Med. 2013;64:165-74. doi: 10.1146/annurev-med-121511-093810. Epub 2012 Nov 1. Review.

PMID:
23121179
28.

Universal influenza vaccine: the holy grail?

Shaw AR.

Expert Rev Vaccines. 2012 Aug;11(8):923-7.

PMID:
23002973
29.

Acceptability of screening to prevent osteoporotic fractures: a qualitative study with older women.

Emmett CL, Redmond NM, Peters TJ, Clarke S, Shepstone L, Lenaghan E, Shaw AR.

Fam Pract. 2012 Apr;29(2):235-42. doi: 10.1093/fampra/cmr069. Epub 2011 Sep 9.

PMID:
21908537
30.

Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.

Bernier AJ, Zhang J, Lillehoj E, Shaw AR, Gunasekara N, Hugh JC.

Mol Cancer. 2011 Jul 28;10:93. doi: 10.1186/1476-4598-10-93.

31.

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.

Talbot HK, Rock MT, Johnson C, Tussey L, Kavita U, Shanker A, Shaw AR, Taylor DN.

PLoS One. 2010 Dec 28;5(12):e14442. doi: 10.1371/journal.pone.0014442.

32.

MT1-MMP association with membrane lipid rafts facilitates G-CSF--induced hematopoietic stem/progenitor cell mobilization.

Shirvaikar N, Marquez-Curtis LA, Shaw AR, Turner AR, Janowska-Wieczorek A.

Exp Hematol. 2010 Sep;38(9):823-35. doi: 10.1016/j.exphem.2010.05.002. Epub 2010 May 13.

PMID:
20471446
33.

Healthcare professionals' views on two computer-based decision aids for women choosing mode of delivery after previous caesarean section: a qualitative study.

Rees KM, Shaw AR, Bennert K, Emmett CL, Montgomery AA.

BJOG. 2009 Jun;116(7):906-14. doi: 10.1111/j.1471-0528.2009.02121.x.

34.

Liquid chromatography electrospray ionization and matrix-assisted laser desorption ionization tandem mass spectrometry for the analysis of lipid raft proteome of monocytes.

Zhang N, Shaw AR, Li N, Chen R, Mak A, Hu X, Young N, Wishart D, Li L.

Anal Chim Acta. 2008 Oct 3;627(1):82-90. doi: 10.1016/j.aca.2008.05.058. Epub 2008 Jun 17.

PMID:
18790130
35.

MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.

Shen Q, Rahn JJ, Zhang J, Gunasekera N, Sun X, Shaw AR, Hendzel MJ, Hoffman P, Bernier A, Hugh JC.

Mol Cancer Res. 2008 Apr;6(4):555-67. doi: 10.1158/1541-7786.MCR-07-2033.

36.

Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care?

Evans MA, Shaw AR, Sharp DJ, Thompson EA, Falk S, Turton P, Thompson T.

Eur J Cancer Care (Engl). 2007 Nov;16(6):517-25.

PMID:
17944766
37.
38.

The rotavirus vaccine saga.

Shaw AR.

Annu Rev Med. 2006;57:167-80. Review.

PMID:
16409143
40.

Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?

Shaw AR.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S246-8. Epub 2005 Oct 5. Review.

PMID:
16213009
41.

Five futures for academic medicine: "speed networking" may be one way forward.

Ridd MJ, Shaw AR.

BMJ. 2005 Sep 24;331(7518):695. No abstract available.

42.

Membrane cholesterol content modulates activation of BK channels in colonic epithelia.

Lam RS, Shaw AR, Duszyk M.

Biochim Biophys Acta. 2004 Dec 15;1667(2):241-8.

43.

Stachybotrys chartarum alters surfactant-related phospholipid synthesis and CTP:cholinephosphate cytidylyltransferase activity in isolated fetal rat type II cells.

Hastings C, Rand T, Bergen HT, Thliveris JA, Shaw AR, Lombaert GA, Mantsch HH, Giles BL, Dakshinamurti S, Scott JE.

Toxicol Sci. 2005 Mar;84(1):186-94. Epub 2004 Dec 1.

PMID:
15574675
45.

Comparative study of influenza virus replication in Vero and MDCK cell lines.

Youil R, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Kiseleva I, Shaw AR, DiStefano D.

J Virol Methods. 2004 Sep 1;120(1):23-31.

PMID:
15234806
46.

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

Youil R, Kiseleva I, Kwan WS, Szymkowiak C, Toner TJ, Su Q, Klimov A, Rudenko L, Shaw AR.

Virus Res. 2004 Jun 15;102(2):165-76.

PMID:
15084398
47.

Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4.

Clark HF, Lawley D, Shrager D, Jean-Guillaume D, Offit PA, Whang SY, Eiden JJ, Bennett PS, Kaplan KM, Shaw AR.

Pediatr Infect Dis J. 2004 Mar;23(3):206-11.

PMID:
15014293
48.

The CD20 calcium channel is localized to microvilli and constitutively associated with membrane rafts: antibody binding increases the affinity of the association through an epitope-dependent cross-linking-independent mechanism.

Li H, Ayer LM, Polyak MJ, Mutch CM, Petrie RJ, Gauthier L, Shariat N, Hendzel MJ, Shaw AR, Patel KD, Deans JP.

J Biol Chem. 2004 May 7;279(19):19893-901. Epub 2004 Feb 19.

49.

Human papillomavirus vaccines and prevention of cervical cancer.

Jansen KU, Shaw AR.

Annu Rev Med. 2004;55:319-31. Review.

PMID:
14746524
50.

Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.

Kiseleva I, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rudenko L, Shaw AR, Youil R.

J Virol Methods. 2004 Mar 1;116(1):71-8.

PMID:
14715309

Supplemental Content

Support Center